Inogen Inc
INGNInogen Inc (INGN) is a medical technology company that specializes in designing and manufacturing portable oxygen concentrators for people with respiratory conditions. Founded in 2001, Inogen's innovative devices enable patients to maintain greater mobility and independence while receiving oxygen therapy. The company's products are used primarily in the home and during travel, offering a portable alternative to traditional oxygen tanks.
Company News
The global oxygen therapy equipment market is expected to grow from ~$3 billion in 2024 to ~$6 billion by 2032, driven by rising respiratory disorders, increased critical care utilization, and technological advancements in oxygen delivery systems.
Inogen is well-positioned for growth in the portable oxygen concentrator (POC) market, with a strong product portfolio and solid Q2 results. However, it faces stiff competition and forex volatility. The company's stock has outperformed the industry and the S&P 500 year-to-date.
Inogen, Inc. is well-poised for growth in the portable oxygen concentrator (POC) market, driven by a strong product portfolio and solid Q1 2024 performance. However, the company faces stiff competition and forex volatility, which are major downsides.
INGN earnings call for the period ending September 30, 2021.
Shares of Inogen Inc. plunged to pace all decliners Thursday, after the portable oxygen container (POC) company reported a surprise second-quarter profit and a big revenue beat, but warned that the semiconductor shortage will likely keep hurting sales and margins for the next year.
